Home › Obesitas › Florida › Hialeah
Obesitas klinische studies in Hialeah, FL
13 studies voor Obesitas zoeken deelnemers op locaties in en rond Hialeah (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RekruterenFase 2
- AGA Clinical Trials, Hialeah
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RekruterenFase 3
- Miguel Rebollar PA, Hialeah
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruterenFase 3
- Elite Cardiac Research Center LLC, Hialeah
- Elite Clinical Research, Hialeah
- Panax Clinical Research, Miami Lakes · 4 mijl verwijderd
- en nog 2
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RekruterenFase 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mijl verwijderd
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RekruterenFase 3
- Elite Cardiac Research Center LLC, Hialeah
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RekruterenFase 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mijl verwijderd
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RekruterenFase 4
- NeoClinical Research, Hialeah
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RekruterenFase 3
- Kailera Clinical Site, Miami Lakes · 4 mijl verwijderd
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RekruterenFase 3
- Indago Research and Health Center, Miami Lakes · 4 mijl verwijderd
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RekruterenFase 3
- San Marcus Research Clinic Inc, Miami Lakes · 4 mijl verwijderd
- Indago Research and Health Center, Miami Lakes · 4 mijl verwijderd
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RekruterenFase 3
- Aga Clinical Trials, Hialeah
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RekruterenFase 3
- Inpatient Research Clinic LLC, Miami Lakes · 4 mijl verwijderd
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
RekruterenFase 3
- Angels Clinical Research Institute, Miami Lakes · 4 mijl verwijderd
Obesitas studies in andere steden
- Houston, TX43 studies
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL31 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Las Vegas, NV27 studies
- Miami, FL27 studies
- Baltimore, MD25 studies
- Jacksonville, FL25 studies
Andere studies in Hialeah
- Schizofrenie13 studies
- Hartfalen12 studies
- Type 2-diabetes10 studies
- Overgewicht10 studies
- Steatotische leveraandoening9 studies
- COPD8 studies
- Ernstige depressieve stoornis8 studies
- Atherosclerose8 studies
- Ziekte van Alzheimer6 studies
- Post-COVID-aandoeningen (Long COVID)6 studies
- Kanker (alle vormen)6 studies
- Cardiovasculaire ziekte6 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.